Showing results (1-10 of 166) with videos related to
Sort By:
Pageof 17
Statistics in Medicine|June 28, 2012
Current development in clinical trials: issues old and newDavid L DeMetsClinical Trials (London, England)|December 16, 2006
Futility approaches to interim monitoring by data monitoring committeesDavid L DemetsJournal of Biopharmaceutical Statistics|January 31, 2006
Conditional and unconditional confidence intervals following a group sequential testXiaoyin Fan, David L DeMetsJournal of Biopharmaceutical Statistics|November 9, 2010
Review of draft FDA adaptive design guidanceThomas Cook, David L DeMetsClinical Trials (London, England)|October 25, 2021
Data monitoring committee interim reports: We must get there soon!David L DeMets, Janet WittesStatistics in Medicine|May 4, 2004
The independent statistician for data monitoring committeesDavid L DeMets, Thomas R FlemingJournal of Clinical Epidemiology|July 14, 2020
Achieving effective informed oversight by DMCs in COVID clinical trialsDavid L DeMets, Thomas R FlemingClinical Trials (London, England)|June 16, 2006
An Institutional Review Board dilemma: responsible for safety monitoring but not in controlDavid L DeMets, Norman Fost, Madison PowersBiometrics|March 23, 2004
Design and analysis of group sequential clinical trials with multiple primary endpointsMichael R Kosorok, Shi Yuanjun, David L DeMetsPageof 17